Donna MacKinnon‐Cameron

Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial

Scott A. Halperin, Lingyun Ye, Donna MacKinnon‐Cameron et al. · The Lancet · 2021 · 230 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +8

Kinetics of the Antibody Response to Tetanus-Diphtheria-Acellular Pertussis Vaccine in Women of Childbearing Age and Postpartum Women

Beth Halperin, Anne Morris, Donna MacKinnon‐Cameron et al. · Clinical Infectious Diseases · 2011 · 165 citations · Full text

Breast Milk Levels, Pertussis Infection, Reproductive Health +20

The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People

Melissa K. Andrew, Vivek Shinde, Lingyun Ye et al. · The Journal of Infectious Diseases · 2017 · 160 citations · Full text

A Randomized Controlled Trial of the Safety and Immunogenicity of Tetanus, Diphtheria, and Acellular Pertussis Vaccine Immunization During Pregnancy and Subsequent Infant Immune Response

Scott A. Halperin, Joanne M. Langley, Lingyun Ye et al. · Clinical Infectious Diseases · 2018 · 107 citations · Full text

The challenge of vaccinating adults: attitudes and beliefs of the Canadian public and healthcare providers

Donna MacDougall, Beth Halperin, Donna MacKinnon‐Cameron et al. · BMJ Open · 2015 · 101 citations · Full text